European Companies Search Engine

Reg­is­tra­tion · Managing Director: Detlev Hessenbruch · Capital: €25,000 · Share­holder agreement · Legal form: GmbH · Proxy policy · Corporate Purpose Hrb 15 Aug 2014 German Trade Register Announcements, Germany

Overview

Text

HRB 11692 CB: Adverio Pharma GmbH,
Unnamed street ??, 12529 Schönefeld, Germany
. The aim is to preserve and manage intellectual property, in particular industrial property rights such as patents, trade marks, utility and design models and know-how, as well as their commercial exploitation in the context of existing or concluded cooperation with third parties worldwide in the pharmaceutical industry sector. Capital: EUR 25,000.00; Representation: The company has one or more directors. If a managing director is appointed, he represents the company alone. If several directors have been appointed, the company is represented jointly by two directors or by a managing director in community with one authorized representative. Board of Management: Managing Director: 1. Dr. Hessenbruch, Detlev, *??.??.????, Potsdam; Legal form: LLC; Company contract of: July 8, 2014

This filing was translated from German to English. The filing refers to a past date, and does not necessarily reflect the current state. The latest known state is available on the following page: Adverio Pharma GmbH, Leverkusen, Germany.